Use of intravenous lidocaine to treat dexmedetomidine-induced bradycardia in sedated and anesthetized dogs.
bradycardia
dexmedetomidine
dog
lidocaine
Journal
Veterinary anaesthesia and analgesia
ISSN: 1467-2995
Titre abrégé: Vet Anaesth Analg
Pays: United States
ID NLM: 100956422
Informations de publication
Date de publication:
Mar 2021
Mar 2021
Historique:
received:
17
08
2020
revised:
18
11
2020
accepted:
21
11
2020
pubmed:
25
1
2021
medline:
25
11
2021
entrez:
24
1
2021
Statut:
ppublish
Résumé
To assess cardiopulmonary function in sedated and anesthetized dogs administered intravenous (IV) dexmedetomidine and subsequently administered IV lidocaine to treat dexmedetomidine-induced bradycardia. Prospective, randomized, crossover experimental trial. A total of six purpose-bred female Beagle dogs, weighing 9.1 ± 0.6 kg (mean ± standard deviation). Dogs were randomly assigned to one of three treatments: dexmedetomidine (10 μg kg When administered after a bolus of dexmedetomidine, lidocaine bolus and L-CRI significantly increased heart rate and cardiac index, decreased mean blood pressure, systemic vascular resistance index and oxygen extraction ratio, and did not affect stroke volume index in all treatments. Lidocaine was an effective treatment for dexmedetomidine-induced bradycardia in healthy research dogs.
Identifiants
pubmed: 33485784
pii: S1467-2987(20)30279-8
doi: 10.1016/j.vaa.2020.11.005
pii:
doi:
Substances chimiques
Anesthetics, Inhalation
0
Dexmedetomidine
67VB76HONO
Lidocaine
98PI200987
Isoflurane
CYS9AKD70P
Types de publication
Journal Article
Randomized Controlled Trial, Veterinary
Langues
eng
Sous-ensembles de citation
IM
Pagination
174-186Informations de copyright
Copyright © 2020 Association of Veterinary Anaesthetists and American College of Veterinary Anesthesia and Analgesia. Published by Elsevier Ltd. All rights reserved.